Eisai
4523.T
$34.30
Share price
0.84%
Change (1 day)
-35.68%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Earnings for Eisai (4523.T)
Earnings in 2024 (TTM): S$0.59 Billion
According to Eisai's latest financial reports the company's current earnings are S$5.06 Billion. In 2023 the company made an earning of S$0.68 Billion, an increase over its 2022 earnings that were of -S$30.09 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eisai from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | S$0.59 B | -14.34% |
| 2023 | S$0.68 B | -2392.87% |
| 2022 | -S$30.09 Million | -103.6% |
| 2021 | S$0.83 B | -39.52% |
| 2020 | S$1.38 B | 7.3% |
| 2019 | S$1.28 B | 17.23% |
| 2018 | S$1.09 B | 86.06% |
| 2017 | S$0.59 B | -23.64% |
| 2016 | S$0.77 B | 27.28% |
| 2015 | S$0.60 B | 22.08% |
| 2014 | S$0.49 B | -46.11% |
| 2013 | S$0.92 B | -21.67% |
| 2012 | S$1.17 B | -20.72% |
| 2011 | S$1.48 B | -8.44% |
| 2010 | S$1.62 B | 18.85% |
| 2009 | S$1.36 B |